Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis, Two Blades Ink TALEN Technology Cross-licensing Deal

NEW YORK (GenomeWeb) – Ag-bio organizations Cellectis Plant Sciences and the Two Blades Foundation announced that they have signed a cross-licensing agreement for their respective TAL effector nuclease gene-editing technologies.

Under the deal, Two Blades has received a license to Cellectis' TALEN technology for non-profit uses, including its efforts to support subsistence farming, as well as certain commercial applications related to its ongoing disease-resistance programs.

Cellectis has received a license to Two Blades' TAL effector code technology related to nucleases for commercial uses in certain undisclosed crop plants. Cellectis has also been granted an option to expand its license to additional crops.

Financial terms of the arrangement were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.